Addition of IVIGs to cultured B lymphocytes did not affect cell viability
| Time, days . | Apoptotic cells and cell viability . | |||
|---|---|---|---|---|
| Control . | IVIGs . | |||
| Annexin V/PI, % . | Viable cells, % . | Annexin V/PI, % . | Viable cells, % . | |
| 0 | 98.7 | 96 | 98.7 | 96 |
| 1 | 83.6 | 92 | 89.9 | 86 |
| 2 | 86.0 | 87 | 93.1 | 90 |
| 3 | 92.0 | 88 | 92.8 | 90 |
| 4 | 82.4 | 89 | 89.4 | 80 |
| Time, days . | Apoptotic cells and cell viability . | |||
|---|---|---|---|---|
| Control . | IVIGs . | |||
| Annexin V/PI, % . | Viable cells, % . | Annexin V/PI, % . | Viable cells, % . | |
| 0 | 98.7 | 96 | 98.7 | 96 |
| 1 | 83.6 | 92 | 89.9 | 86 |
| 2 | 86.0 | 87 | 93.1 | 90 |
| 3 | 92.0 | 88 | 92.8 | 90 |
| 4 | 82.4 | 89 | 89.4 | 80 |
Purified human B lymphocytes were cultured with IL-4 and L4.5 cells in the presence of human serum albumin (9 mg/mL) and sucrose (15 mg/mL) or IVIGs (15 mg/mL). Apoptosis and necrosis levels were determined with annexin V and PI staining. Viable cell proportions were determined by viable cell count using trypan blue exclusion.